MedPath

Mazindol for Cocaine Abuse - 2

Phase 2
Completed
Conditions
Cocaine-Related Disorders
Registration Number
NCT00000277
Lead Sponsor
Yale University
Brief Summary

The purpose of this study is to evaluate high and low dose mazindol for cocaine abuse.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Retention
Drug use
Side effects
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

VA Connecticut Healthcare System

🇺🇸

New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath